James L. Tyree, Director at Innoviva, holds 188.25K shares in Assertio Therapeutics (Ticker: ASRT), holds 3.46K shares in Genelux Corp. (Ticker: GNLX), holds 0.00 shares in ChemoCentryx (Ticker: CCXI). Most recently, James L. Tyree Sold ― shares of Assertio Therapeutics on Mar 15, 2024 for an estimated value of 11.38K.